Nonprofit Chronicles

Journalism about foundations, nonprofits and their impact

This is a remarkable moment for psychedelics. Elite universities, including Johns Hopkins and Imperial College in London, have opened centers to research the medical benefits of such drugs as psilocybin, a hallucinogen found in certain mushrooms. The nonprofit Multidisciplinary Association for Psychedelic Research (MAPS) is recruiting people suffering from PTSD to participate in FDA-approved clinical trials using MDMA, better known as …

Continue reading

Psychedelic drugs are having a moment in the sun. They have great potential, we’re learning, as a treatment for a variety of mental illnesses, including post-traumatic stress disorder and depression. They are also attracting interest as a gateway to meaningful experiences that, advocates say, should be available to all. Philanthropists are taking note. More donors — though …

Continue reading